11 October 2023
11 October 2023
Psychedelic medicine has long been considered taboo by the healthcare industry due to its association with recreational drug use.
The micro and nano-roughened surface was designed to improve fixation of the interbody fusion implant to the adjacent bone.
US firm, Histosonics, has seen its novel device get the go ahead to go to market from the FDA following extensive trials across 13 sites in the US and Europe
Six-month randomized controlled trial in the US evaluates the efficacy of MODIA in conjunction with sublingual buprenorphine naloxone for the treatment of opioid abuse.
The addition of aidhere’s Zanadio product places Sidekick Health at the forefront of the growing PDT market.
The IDE is for a second multicentre study to test the sensor in New York Heart Association (NYHA) class II heart failure patients.
PFA catheters are indicated to treat atrial fibrillation (Afib) during electrophysiology procedures.
The bedside device uses radar technology to screen for sleep apnoea and measure vital signs in a rapidly growing remote monitoring market.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.
